4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0000950170-24-099593
Options or other derivatives
- Chief Executive Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schaefer Thomas J. Chief Executive Officer | 2024-08-19 | Grant or award · Stock Option (Right to Buy) | +20,000 | 25,475 | D | ||
Loading xslF345X05/ownership.xml…